A carregar...
The phosphatase PPM1A inhibits triple negative breast cancer growth by blocking cell cycle progression
Estrogen receptor (ER)-negative, progesterone receptor (PR)-negative and HER2-negative, or “triple negative,” breast cancer (TNBC) is a poor prognosis clinical subtype that occurs more frequently in younger women and is commonly treated with toxic chemotherapy. Effective targeted therapy for TNBC is...
Na minha lista:
| Publicado no: | NPJ Breast Cancer |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Nature Publishing Group UK
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6659706/ https://ncbi.nlm.nih.gov/pubmed/31372497 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41523-019-0118-6 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|